AMRN Q3 2021 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$335M

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$142M-9.2% YoY

Gross Profit

$112M78.7% margin

Operating Income

-$13M-9.2% margin

Net Income

-$13M-9.3% margin

EPS (Diluted)

$-0.66

QoQ Revenue Growth

-8.1%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1.0B

Total Liabilities

$393M

Stockholders' Equity

$642M

Cash & Equivalents

$223M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$142M	$156M	-9.2%
Gross Profit	$112M	$123M	-9.4%
Operating Income	-$13M	-$7M	-88.4%
Net Income	-$13M	-$7M	-93.7%

Revenue Segments

Product

$141M100%

Licensing And Royalty

$596,0000%